An average GP practice with 2000 patients will have approximately
150 men registered with urinary symptoms severe enough to
consider seeking treatment at some point in time.
Traditionally, the successful management of
symptomatic Benign Prostatic Hypertrophy
(BPH) has beenTransurethral Resection of
the Prostate (TURP), which was viewed by
both surgeons and General Practitioners as
the gold standard procedure, given its proven
efficiency and long-term durability.
When the GreenLight PVP laser therapy
was introduced to the UK five years ago
by Consultant Urological Surgeon, Mr
Gordon Muir, the laser technique not only
demonstrated comparable advantages to
those of TURP, but also highlighted the
unique benefits of being a daycase, with
reduced blood loss, few complications
(if any) and minimal morbidity.
In 2004, the GreenLight laser procedure
at King’s College Hospital received the UK
Clinical Excellence Award for Innovation,
soon followed by the approval of the
National Institute for Health and Clinical
Excellence (NICE).Today, more than 1000
urologists over 30 countries, (many trained
by Mr Muir), perform the minimal invasive
operation and over 150,000 patients have
successfully been treated.
In January this year, Executive Director, John
Reay, decided to equip the hospital with the
most advanced model of the GreenLight, the
GreenLight HPS, with a view to providing his
patients with a laser surgical alternative to
TURP, that had proven comparable benefits.
Mr Gordon Muir, who has performed over
1000 GreenLight operations and who was
the first surgeon in Europe to use the HPS,
confirmed over 95% success rate in men with
catheters for retention of urine, thanks to the
new technology and reported overall excellent
results from a surgical perspective, coupled
with very positive patient feedback.
Mr Muir also observed that the HPS definitely
sped up the process of removing obstructing
prostate tissue, allowed more precision when
compared with its predecessor, reduced time
under anaesthesia and, ultimately, increased
safety for patients.
What is the GreenLight laser?
The GreenLight PVP technology releases
high powered laser energy into the cells by
means of continuous saline irrigation, which
is then absorbed by tissue and haemoglobin,
leading to a rapid heating of cells and
vaporisation of tissue.
• Greater than 100% improvement in urinary
• Over 50% decrease in symptoms
• Spontaneous voiding for patients with
• Immediate removal of the prostatic bladder
• Comparable operative time
• Proven capability
Observations of the GreenLight PVP during
clinical studies concluded to the durable
capability of the procedure and its long-term
outcomes, with significant improvements in
maximum urinary flow rate. 4-5 year follow-
up from a number of International centres,
including ours, suggests positive durable results.
Advantages over TURP
Clinical studies have shown a low risk of
mainly minor adverse events.TURP can be
accompanied by risks of postoperative urinary
retention, infection, incontinence, erectile
dysfunction, impotence, blood transfusion,
capsular perforation, clot retention.
With the GreenLight laser therapy, the risks
of serious bleeding,TUR Syndrome and
erectile dysfunction are close to nil. Economic
studies have highlighted the benefits of the
GreenLight, in terms of in-hospital costs, and
mostly, patients are able to return to normal
activity very rapidly.
Traditionally, open prostatectomy was the
operation of choice for patients with large
prostates, due to the relative inability of
TURP to resect larger glands over 80-100ml
due to the risks of TUR Syndrome and
severe bleeding. Since then, the GreenLight
laser therapy has proved to be a very safe
option in treating these large prostates, and
many of these patients can even be treated
in a daycase setting.
TURP carries a significant risk of absorbing
the irrigating fluid that may cause pulmonary
and cerebral oedema, in extreme cases
leading to ITU treatment. Our research on
the GreenLight laser has shown that this
potential complication is abolished.
High Risk Patients
For patients on anticoagulant therapies, with
bleeding disorders or at risk of cardiovascular
co-morbidity, the GreenLight laser procedure
offers a reasonable surgical alternative due to
its haemostatic nature, significantly decreasing
the risks of bleeding, clot retention, transfusion,
sometimes seen withTURP.
• Immediate symptom relief
• Rapid flow rate improvement
• Fast recovery times
• Daycase procedure with some
patients resuming work the
GreenLight is a trademark of American Medical Systems Inc.
Mr Gordon Muir is an International Mentor for the GreenLight procedure and a member of the Renaissance Healthcare Group.
Based on short-terms results since 2002.
Data presented at the European,American and British Annual Urological Meetings, and published in a number of international journals.
Patient Programme and
General Practitioners wishing to illustrate
the procedure to their patients can request
a free patient information CD.
We understand the importance of
Continuing Professional Development and
as such, we are also offering an online
workshop for the GreenLight procedure.
To obtain details on either
option simply call us on: